Sign in
Companies / VTRS vs JNJ

VTRS vs JNJ: Viatris and Johnson & Johnson

Pharmaceuticals
Compare more companies

Viatris (VTRS) reported $14.3B in revenue against a -24.6% net margin, while Johnson & Johnson (JNJ) reported $94.2B at a 28.5% net margin, most recently.

MetricVTRSJNJ
Revenue$14.3B$94.2B
Net Income$-3.5B$26.8B
Gross Margin35.1%67.9%
Operating Margin-18.6%—
EPS (Diluted)$-3.00$11.03
Free Cash Flow$1.9B$19.7B
Total Debt$14.4B$49.9B
P/E Ration/m18.8×
P/B Ration/mn/m
Stock Price$19.00$272.48
Free: last 5 years
Fiscal yearFY2018 🔒FY2019 🔒FY2021FY2022FY2023FY2024FY2025
VTRS Revenue••••••••••$17.9B$16.3B$15.4B$14.7B$14.3B
JNJ Revenue••••••••••$82.6B$78.7B$85.2B$88.8B$94.2B

More on VTRS

More on JNJ

Other comparisons